Pharmaceutical Manufacturing Market Is Expected To Grow At a CAGR Of 7.0% FROM 2018-2027.


According to Stratistics MRC, the Global Pharmaceutical Manufacturing Market is expected to grow at a CAGR of 7.0% during the forecast period. Increasing prevalence of chronic diseases and the growing demand for medications are the major factors propelling the market growth. However, high initial cost and stringent government regulations are restraining the market growth.

Request for sample here: “Global Pharmaceutical Manufacturing Market

Pharmaceutical manufacturing can be defined as the process of production of pharmaceutical drugs on an industrial scale. The drug manufacturing can be divided into a series of unit operations, such as milling, coating, tablet pressing, and others. In uninterrupted manufacturing, input raw materials and energy are fed into the system at a steady rate, and at the same time, a constant extraction of output products is achieved. The process performance is heavily dependent on stability of the material flow rate. For powder-based continuous processes, it is critical to feed powders consistently and accurately into subsequent unit operations of the process line, as feeding is typically the first unit operation.

Opportunity: The patent expiration of drugs would provide ample opportunities for the market growth.

The patent expiration of several brand-name drugs will create growth opportunities in the short term. In addition the healthcare reform is expected to benefit the industry, with more consumers gaining insurance coverage for prescription drugs, improved generic drug approval processes and an established pathway to approval for biosimilars.

Driver: The discovery of new pathogens is driving the market growth.

The discovery of numerous new pathogens is taking place frequently as a result of continuous research activities. The development of medicine to treat/ prevent illness due to the same reason, would contribute to the growth of the market.

Request for customization here: “Global Pharmaceutical Manufacturing Market

Depending on route of administration, the oral segment is expected to grow at a significant market share during the forecast period. The manufacturers have had more access to modern technology to facilitate the transition to continuous operations, and new continuous processing equipment is able to adress most unit operations involved in manufacturing of oral drugs.

Europe region is anticipated to hold considerable market share during the forecast period:

By geography, the Europe region is anticipated to hold considerable market share during the forecast period. Increasing focus on clinical research and the growing popularity of branded drugs are the major factors driving the regional market growth. Moreover, countries like France have presence of leading pharmaceutical companies.

Some of the key players profiled in the Pharmaceutical Manufacturing Market include Takeda, Sanofi, Roche, Pfizer, Novo Nordisk, Novartis, Lupin, GlaxoSmithKline, Gilead Sciences, Eli Lily, Merck & Co., Cipla, Astra Zeneca, Amgen, Actavis and Abbott Laboratories.

For more information fill in the Inquiry form at: “Global Pharmaceutical Manufacturing Market

Abbott Laboratories: In February 2020, Abbott and Insulet Corporation has partnered to incorporate Abbott's world-leading1 glucose sensing technology with Insulet's next-generation tubeless system, the Omnipod Horizon™ Automated Insulin Delivery (AID) System (Omnipod Horizon System), to offer personalized automated insulin delivery and care for people living with diabetes.

Merck & Co: In January 2020, Merck completed the acquisition of ArQule through a merger of Merck’s wholly-owned subsidiary with and into ArQule.

About Stratistics MRC:

Stratistics MRC Pvt Ltd. is a market research firm serving the fortune 500 companies across the world with market intelligence. We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

We have a core research team with research analysts across the industry verticals to serve our varied customers such as technology suppliers, manufacturers, distributors, end-users, consulting companies, investment firms and research institutes. We ensure that our research reports, white papers, policy briefs provide result-oriented findings and recommendations. Our research reports help you to make better decisions in building the organization present in a global scenario. Our consultancy services offer you with the highly qualified professional research team to match your research needs. We are in the process of addressing the challenges of our clients and able to deliver the quality outputs to meet their business objectives and goals in a potential way. We invest more in building our teams and enhance our client relationships across the geographies where we work.

James Lamb
United States Direct:+1-301-202-5929
Corporate Sales Specialist